(Q51794028)

12 April 2018

title

Long-term migraine prevention with topiramate: open-label extension of pivotal trials. (English)

1 reference

12 April 2018

1 reference

Hans-Christoph Diener

3

object named as

Hans-Christoph Diener

1 reference

12 April 2018

Alan Rapoport

1

1 reference

12 April 2018

Alexander Mauskop

2

1 reference

12 April 2018

Susanne Schwalen

4

1 reference

12 April 2018

Joop Pfeil

5

1 reference

12 April 2018

publication date

1 July 2006

1 reference

12 April 2018

published in

Headache

1 reference

12 April 2018

volume

46

1 reference

12 April 2018

issue

7

1 reference

12 April 2018

page(s)

1151-1160

1 reference

12 April 2018

Prevalence and burden of migraine in the United States: data from the American Migraine Study II.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00506.X

Migraine headache disability and health-related quality-of-life: a population-based case-control study from England.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00506.X

Migraine diagnosis and treatment: results from the American Migraine Study II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00506.X

Burden of migraine in the United States: disability and economic costs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00506.X

Features of medication overuse headache following overuse of different acute headache drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00506.X

Pharmacologic management of acute attacks of migraine and prevention of migraine headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00506.X

Topiramate in migraine prevention: results of a large controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00506.X

Topiramate for migraine prevention: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00506.X

Topiramate in migraine prophylaxis--results from a placebo-controlled trial with propranolol as an active control

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00506.X

Topiramate alters excitatory synaptic transmission in mouse hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00506.X

Topiramate attenuates voltage-gated sodium currents in rat cerebellar granule cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00506.X

Plasma and whole blood pharmacokinetics of topiramate: the role of carbonic anhydrase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00506.X

Characterization and prediction of emergency department use in chronic daily headache patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00506.X

Post-marketing cohort study comparing the safety and efficacy of flunarizine and propranolol in the prophylaxis of migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2006.00506.X

Propranolol for migraine prophylaxis

21 January 2018

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1002/14651858.CD003225.PUB2

Identifiers

DOI

10.1111/J.1526-4610.2006.00506.X

1 reference

12 April 2018

1 reference

12 April 2018